Internal Medicine, Endocrinology, Diabetes, & Metabolism · Pittsburgh, PA
NPI
1457616419
Since 2012
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
5806 Ellsworth Ave Apt 4
Pittsburgh, PA, 15232
Phone (412) 626-2670
Groups this clinician bills Medicare through
Medicare paid, 2024
$231K
3,712 services
Medicare patients, 2024
500
Average age 71
Drug cost, 2024
$2.7M
7,549 prescriptions
Company payments, 2025
$350
From 5 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Taher Elsdai was code 99232 (hospital e&m - subsequent), 2,419 times for 130 patients. In total Taher Elsdai billed 3,712 services in 14 codes, and Medicare paid $231K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2018-07-26.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99232 Hospital E&M - Subsequent | Facility | 2,419 | 130 | $58.65 | $142K |
| 99214 Office E&M - Established | Office | 618 | 331 | $81.68 | $50K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 154 | 151 | $12.49 | $1,923 |
| 95251 Test - Miscellaneous | Office | 147 | 71 | $25.02 | $3,678 |
| 99222 Hospital E&M - Initial | Facility | 139 | 123 | $96.41 | $13K |
| 99309 SNF E&M | Facility | 95 | 12 | $80.76 | $7,672 |
| 99204 Office E&M - New | Office | 75 | 75 | $100.42 | $7,531 |
| 99305 SNF E&M | Facility | 13 | 12 | $92.67 | $1,205 |
By year: 2022 $234K for 3,670 services; 2023 $260K for 3,777 services; 2024 $231K for 3,712 services.
Medicare prescription drug claims, 2024
In 2024, the drug Taher Elsdai prescribed most often to Medicare patients was Levothyroxine Sodium, with 1,212 prescriptions and refills. In total Taher Elsdai wrote 7,549 Medicare prescriptions that cost $2.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 1,212 | 2,214 | 257 | $16K |
| Ozempic Semaglutide | 607 | 826 | 119 | $759K |
| Jardiance Empagliflozin | 452 | 668 | 92 | $379K |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 397 | 937 | 136 | $55K |
| Metformin Hcl Er Metformin Hcl | 375 | 731 | 94 | $6,414 |
| Glipizide Er Glipizide | 338 | 553 | 79 | $4,044 |
| Metformin Hcl Generic | 338 | 720 | 90 | $3,358 |
| Synthroid Levothyroxine Sodium | 257 | 608 | 68 | $19K |
| Trulicity Dulaglutide | 236 | 308 | 46 | $288K |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 172 | 406 | 61 | $20K |
| Humalog Kwikpen U-100 Insulin Lispro | 164 | 358 | 67 | $51K |
| Methimazole Generic | 149 | 277 | 36 | $1,406 |
| Hydrocortisone Generic | 143 | 218 | 31 | $5,444 |
| Glipizide Generic | 124 | 201 | 27 | $1,170 |
| Tradjenta Linagliptin | 122 | 166 | 26 | $79K |
Brand drugs: 3,652 claims; generic drugs: 3,452 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Taher Elsdai $350 ($350 in general payments such as food, travel and fees) from 5 companies. The largest payer was Novo Nordisk Inc with $153.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.